176 related articles for article (PubMed ID: 35545457)
1. Uninterrupted Continuation of VV-ECMO Without Anticoagulation for 44 Days in COVID-19 ARDS: A Precarious Quandary.
Patel SP; Solomon BJ; Pascotto RD; D'Orazio SE; Navas EV; Cubeddu RJ; Cudemus GA
J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):3193-3196. PubMed ID: 35545457
[TBL] [Abstract][Full Text] [Related]
2. Heparin-induced thrombocytopenia in COVID-19 patients with severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation: two case reports.
Bidar F; Hékimian G; Martin-Toutain I; Lebreton G; Combes A; Frère C
J Artif Organs; 2021 Jun; 24(2):277-281. PubMed ID: 32789604
[TBL] [Abstract][Full Text] [Related]
3. Eleven Years of Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: From H1N1 to SARS-CoV-2. Experience and Perspectives of a National Referral Center.
Pieri M; Donatelli V; Calabrò MG; Scandroglio AM; Pappalardo F; Zangrillo A
J Cardiothorac Vasc Anesth; 2022 Jun; 36(6):1703-1708. PubMed ID: 34686438
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal Carbon Dioxide Removal to De-escalate Venovenous Extracorporeal Membrane Oxygenation in Severe COVID-19 Acute Respiratory Distress Syndrome.
Cambria G; Spelde AE; Olia SE; Biscotti M; Mackay E; Ibrahim M; Cevasco M; Bermudez C; Vernick W; Gutsche J; Usman AA
J Cardiothorac Vasc Anesth; 2024 Mar; 38(3):717-723. PubMed ID: 38212185
[TBL] [Abstract][Full Text] [Related]
5. Dynamic coagulofibrinolytic responses under long-term VV-ECMO management without anticoagulation in a COVID-19-ARDS patient: A case report.
Matsumoto H; Kikuchi S; Murata S; Ohshita M; Harima Y; Annen S; Mukai N; Nakabayashi Y; Ogawa S; Okita M; Takeba J; Sato N
Medicine (Baltimore); 2023 Jan; 102(4):e32817. PubMed ID: 36705388
[TBL] [Abstract][Full Text] [Related]
6. Venovenous extracorporeal membrane oxygenation after cardiac arrest for acute respiratory distress syndrome caused by Legionella: a case report.
Grotberg JC; Schulte L; Schumer E; Sullivan M; Kotkar K; Masood MF; Pawale A
J Cardiothorac Surg; 2024 Jan; 19(1):27. PubMed ID: 38281956
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of thromboelastography in the management of anticoagulation for veno-venous extracorporeal membrane oxygenation in a coronavirus disease 2019 patient: A case report.
Nakashima R; Nishihara M; Iyonaga T; Iwasaka S; Yamamoto Y; Shono Y; Maki J; Tokuda K; Akahoshi T; Higo T; Kitazono T; Tsutsui H
Medicine (Baltimore); 2021 Jun; 100(23):e26313. PubMed ID: 34115042
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation strategies in COVID-19 infected patients receiving ECMO support.
Diaz D; Martinez J; Bushman G; Wolowich WR
J Extra Corpor Technol; 2023 Sep; 55(3):121-129. PubMed ID: 37682210
[TBL] [Abstract][Full Text] [Related]
9. Venovenous Extracorporeal Membrane Oxygenation in Awake Non-Intubated Patients With COVID-19 ARDS at High Risk for Barotrauma.
Paternoster G; Bertini P; Belletti A; Landoni G; Gallotta S; Palumbo D; Isirdi A; Guarracino F
J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):2975-2982. PubMed ID: 35537972
[TBL] [Abstract][Full Text] [Related]
10. A Case Series of Devastating Intracranial Hemorrhage During Venovenous Extracorporeal Membrane Oxygenation for COVID-19.
Usman AA; Han J; Acker A; Olia SE; Bermudez C; Cucchiara B; Mikkelsen ME; Wald J; Mackay E; Szeto W; Vernick WJ; Gutsche JT
J Cardiothorac Vasc Anesth; 2020 Nov; 34(11):3006-3012. PubMed ID: 32828653
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation and Transfusions Management in Veno-Venous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: Assessment of Factors Associated With Transfusion Requirements and Mortality.
Martucci G; Panarello G; Occhipinti G; Ferrazza V; Tuzzolino F; Bellavia D; Sanfilippo F; Santonocito C; Bertani A; Vitulo P; Pilato M; Arcadipane A
J Intensive Care Med; 2019 Aug; 34(8):630-639. PubMed ID: 28460592
[TBL] [Abstract][Full Text] [Related]
12. Reduced anticoagulation strategy is associated with a lower incidence of intracerebral hemorrhage in COVID-19 patients on extracorporeal membrane oxygenation.
Hofmaenner DA; Furfaro D; Wild LC; Wendel-Garcia PD; Baedorf Kassis E; Pannu A; Welte T; Erlebach R; Stahl K; Grandin EW; Putensen C; Schuepbach RA; Shaefi S; David S; Seeliger B; Bode C;
Intensive Care Med Exp; 2023 Jun; 11(1):38. PubMed ID: 37302996
[TBL] [Abstract][Full Text] [Related]
13. Intracerebral Hemorrhage in COVID-19 Patients with Pulmonary Failure: A Propensity Score-Matched Registry Study.
Lang CN; Dettinger JS; Berchtold-Herz M; Utzolino S; Bemtgen X; Zotzmann V; Schmid B; Biever PM; Bode C; Müller-Peltzer K; Duerschmied D; Wengenmayer T; Niesen WD; Staudacher DL
Neurocrit Care; 2021 Jun; 34(3):739-747. PubMed ID: 33619668
[TBL] [Abstract][Full Text] [Related]
14. Mortality Risk Assessment in COVID-19 Venovenous Extracorporeal Membrane Oxygenation.
Tabatabai A; Ghneim MH; Kaczorowski DJ; Shah A; Dave S; Haase DJ; Vesselinov R; Deatrick KB; Rabin J; Rabinowitz RP; Galvagno S; O'Connor JV; Menaker J; Herr DL; Gammie JS; Scalea TM; Madathil RJ
Ann Thorac Surg; 2021 Dec; 112(6):1983-1989. PubMed ID: 33485917
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation Practices during Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure. A Systematic Review.
Sklar MC; Sy E; Lequier L; Fan E; Kanji HD
Ann Am Thorac Soc; 2016 Dec; 13(12):2242-2250. PubMed ID: 27690525
[TBL] [Abstract][Full Text] [Related]
16. Right Ventricular Failure Manifesting in Corona Virus Disease 2019 Acute Respiratory Distress Syndrome: A Call to Transition from Venovenous Extracorporeal Membranous Oxygenation to Right Ventricular Assist Device Extracorporeal Membranous Oxygenation.
Patel SP; Solomon BJ; Pascotto RD; D'Orazio SE; Navas EV; Cubeddu RJ; Cudemus GA
J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):3197-3201. PubMed ID: 35317957
[TBL] [Abstract][Full Text] [Related]
17. Potential for recovery after extremely prolonged VV-ECMO support in well-selected severe COVID-19 patients: a retrospective cohort study.
de Walque JM; de Terwangne C; Jungers R; Pierard S; Beauloye C; Laarbaui F; Dechamps M; Jacquet LM
BMC Pulm Med; 2024 Jan; 24(1):19. PubMed ID: 38191411
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors of Mortality for Patients Receiving Venovenous Extracorporeal Membrane Oxygenation for COVID-19 Acute Respiratory Distress Syndrome.
Bergman ZR; Wothe JK; Alwan FS; Lofrano AE; Tointon KM; Doucette M; Bohman JK; Saavedra-Romero R; Prekker ME; Lusczek ER; Beilman G; Brunsvold ME
Surg Infect (Larchmt); 2021 Dec; 22(10):1086-1092. PubMed ID: 34494893
[No Abstract] [Full Text] [Related]
19. Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.
Heman-Ackah SM; Su YS; Spadola M; Petrov D; Chen HI; Schuster J; Lucas T
Neurosurgery; 2020 Aug; 87(2):E147-E151. PubMed ID: 32424429
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study.
Mayerhöfer T; Joannidis M; Peer A; Perschinka F; Fries D; Mair P; Gasteiger L; Bachler M; Kilo J; Herkner H; Schwameis M; Schellongowski P; Nagler B; Kornfehl A; Staudinger T; Buchtele N
Thromb Res; 2024 Apr; 236():161-166. PubMed ID: 38452448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
